77 related articles for article (PubMed ID: 19418444)
1. The Effect of Curcumin on the Differentiation of Mesenchymal Stem Cells into Mesodermal Lineage.
Gorabi AM; Kiaie N; Hajighasemi S; Jamialahmadi T; Majeed M; Sahebkar A
Molecules; 2019 Nov; 24(22):. PubMed ID: 31703322
[TBL] [Abstract][Full Text] [Related]
2. Application progress of single-cell sequencing technology in mesenchymal stem cells research.
Li H; Wang Y; Zhu G; Ma Q; Huang S; Guo G; Zhu F
Front Cell Dev Biol; 2023; 11():1336482. PubMed ID: 38264356
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.
Quante M; Tu SP; Tomita H; Gonda T; Wang SS; Takashi S; Baik GH; Shibata W; Diprete B; Betz KS; Friedman R; Varro A; Tycko B; Wang TC
Cancer Cell; 2011 Feb; 19(2):257-72. PubMed ID: 21316604
[TBL] [Abstract][Full Text] [Related]
4. Gremlin1 is required for skeletal development and postnatal skeletal homeostasis.
Canalis E; Parker K; Zanotti S
J Cell Physiol; 2012 Jan; 227(1):269-77. PubMed ID: 21412775
[TBL] [Abstract][Full Text] [Related]
5. Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential.
Worthley DL; Churchill M; Compton JT; Tailor Y; Rao M; Si Y; Levin D; Schwartz MG; Uygur A; Hayakawa Y; Gross S; Renz BW; Setlik W; Martinez AN; Chen X; Nizami S; Lee HG; Kang HP; Caldwell JM; Asfaha S; Westphalen CB; Graham T; Jin G; Nagar K; Wang H; Kheirbek MA; Kolhe A; Carpenter J; Glaire M; Nair A; Renders S; Manieri N; Muthupalani S; Fox JG; Reichert M; Giraud AS; Schwabe RF; Pradere JP; Walton K; Prakash A; Gumucio D; Rustgi AK; Stappenbeck TS; Friedman RA; Gershon MD; Sims P; Grikscheit T; Lee FY; Karsenty G; Mukherjee S; Wang TC
Cell; 2015 Jan; 160(1-2):269-84. PubMed ID: 25594183
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy.
Fan XL; Zhang Y; Li X; Fu QL
Cell Mol Life Sci; 2020 Jul; 77(14):2771-2794. PubMed ID: 31965214
[TBL] [Abstract][Full Text] [Related]
7. Moving from the laboratory bench to patients' bedside: considerations for effective therapy with stem cells.
Sherman LS; Munoz J; Patel SA; Dave MA; Paige I; Rameshwar P
Clin Transl Sci; 2011 Oct; 4(5):380-6. PubMed ID: 22029813
[TBL] [Abstract][Full Text] [Related]
8. Bone regeneration: the stem/progenitor cells point of view.
Deschaseaux F; Pontikoglou C; Sensébé L
J Cell Mol Med; 2010 Jan; 14(1-2):103-15. PubMed ID: 19840188
[TBL] [Abstract][Full Text] [Related]
9. Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: a two-stage hypothesis for regulation of MSC fate.
Gregory CA; Ylostalo J; Prockop DJ
Sci STKE; 2005 Jul; 2005(294):pe37. PubMed ID: 16046665
[TBL] [Abstract][Full Text] [Related]
10. Trafficking and differentiation of mesenchymal stem cells.
Liu ZJ; Zhuge Y; Velazquez OC
J Cell Biochem; 2009 Apr; 106(6):984-91. PubMed ID: 19229871
[TBL] [Abstract][Full Text] [Related]
11. Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity.
Delorme B; Ringe J; Pontikoglou C; Gaillard J; Langonné A; Sensebé L; Noël D; Jorgensen C; Häupl T; Charbord P
Stem Cells; 2009 May; 27(5):1142-51. PubMed ID: 19418444
[TBL] [Abstract][Full Text] [Related]
12. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.
Zhao L; Li G; Chan KM; Wang Y; Tang PF
Calcif Tissue Int; 2009 Jan; 84(1):56-64. PubMed ID: 19052794
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells can be differentiated into endothelial cells in vitro.
Oswald J; Boxberger S; Jørgensen B; Feldmann S; Ehninger G; Bornhäuser M; Werner C
Stem Cells; 2004; 22(3):377-84. PubMed ID: 15153614
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.
Wang CH; Ciliberti N; Li SH; Szmitko PE; Weisel RD; Fedak PW; Al-Omran M; Cherng WJ; Li RK; Stanford WL; Verma S
Circulation; 2004 Mar; 109(11):1392-400. PubMed ID: 14993120
[TBL] [Abstract][Full Text] [Related]
15. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
